date:Jul 14, 2012
opinion.
Therefore, the BfR concluded, the NOAEL of 10mg/kg which was used for setting the acute reference dose in the EU can no longer be considered an appropriate point of departure for acute human assessment, especially for the protection of infants. Consequently, the acute reference dose of 0.1mg/kg should be reconsidered.
Furthermore, the BfR recommended that both the NOAEL of 1mg/kg, which was used as a point of departure for chronic human risk assessment, and the acceptable daily intake